Extract and intact and RNA exosomes from plasma
Ended Purchase Order Awarded
- Contract number
- 75N92023P00161
- Awardee
-
Norgen Biotek Corp UEI SB5ZH66FTV27
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $334,355
Award facts
- Opportunity
-
- Extract and intact and RNA exosomes from plasma fo Solicitation · 75N92023Q0669 · Posted Apr 14, 2023
- Contract value 50% obligated
-
- $334,355.00 Current, with exercised options
- $668,710.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for extraction and isolation of RNA exosomes from plasma to support the clinical study, with evaluation criteria including technical approach, qualifications, and price. No set-aside designation was specified. Performance will take place at Norgen Biotek's facility in Ottawa and span from May 2023 to May 2025.
Quick answers
Who was awarded contract 75N92023P00161?
75N92023P00161 was awarded to Norgen Biotek Corp by National Heart Lung and Blood Institute (National Institutes of Health) on May 2, 2023.
How much is contract 75N92023P00161 worth?
The government has obligated $334,355 on 75N92023P00161. Its potential value, with all options, is $668,710.
Which agency awarded contract 75N92023P00161?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92023P00161, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92023P00161 competed?
The extent of competition for 75N92023P00161 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award